Serum Institute of India (SII) CEO Adar Poonawalla said that the vaccination drive against COVID-19 will begin in January next year in India. The company has applied for the authorisation of the vaccine for the emergency use. The government may give a green signal to the pharmaceutical company by the end of 2020.

On Saturday, while addressing the The Economic Times Global Business Summit,   Poonawalla said the vaccination will be completed by October 2021.

“By this month-end, we might get an emergency licence, but the actual licence for wider use might come in at a later date. But we are confident that if the regulators approve, India’s vaccination drive can start by January 2021,” Poonawalla said.

“Once 20% of India gets the coronavirus vaccine, we can hopefully see the confidence and sentiments coming back, and by September-October next year hopefully there will be enough vaccines for everyone and normal life can return,” he added.

Earlier, the Central Drugs Standard Control Organisation (CDSCO) asked the SII and Bharat Biotech to submit additional data on safety and efficiency data for coronavirus vaccine candidates.

According to Poonawalla, the government has planned to procure 300-400 million doses by July 2021. The Serum Institute is planning to manufacture enough COVID-19 vaccines for the government and private investors.